Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAhnDhUC1mAbRyVa7R9UMT92CEzEYzvjOkV1kMkVkLwoY#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "iclusig ponatinib is a kinase inhibitor indicated for the treatment of adult patients with chronic phase accelerated phase or blast phase chronic myeloid leukemia cml or ph all for whom no other tyrosine kinase inhibitor tki therapy is indicated treatment of adult patients with t315i positive cml chronic phase accelerated phase or blast phase or t315i positive philadelphia chromosome positive acute lymphoblastic leukemia ph all iclusig is a kinase inhibitor indicated for the treatment of adult patients with chronic phase accelerated phase or blast phase chronic myeloid leukemia cml or ph all for whom no other tyrosine kinase inhibitor tki therapy is indicated treatment of adult patients with t315i positive cml chronic phase accelerated phase or blast phase or t315i positive philadelphia chromosome positive acute lymphoblastic leukemia ph all 1 limitations of use iclusig is not indicated and is not recommended for the treatment of patients with newly diagnosed chronic phase cml 5 7 limitations of use iclusig is not indicated and is not recommended for the treatment of patients with newly diagnosed chronic phase cml see warnings and precautions 5 7" assertion.
- association object DOID_8552 assertion.
- association predicate treats assertion.
- association subject drugbank:DB08901 assertion.
- association relation TreatmentIndication assertion.
- drugbank:DB08901 category Drug assertion.
- DOID_8552 category Disease assertion.
- association provided_by NeuroDKG assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.